MedTrace Logo

Increased Ketorolac Administration After Cesarean Section and Its Effect on Opioid Use: a Randomized Control Trial

NCT03678675 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2022-08-18

Study results available
· View outcomes & findings →

Summary

To evaluate the efficacy of increased ketorolac in reducing opioid use after cesarean section.

Conditions

  • Post-operative Pain
  • Post-partum Pain
  • Cesarean Section Complications

Interventions

DRUG

Ketorolac

The intervention is a protocol of scheduled IV Ketorolac administered postoperatively.

Sponsors & Collaborators

  • Tufts Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-30
Primary Completion
2022-01-31
Completion
2022-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03678675 on ClinicalTrials.gov